This document discusses using lithium supplementation as a potential public health strategy to reduce antisocial behaviors. It notes that while some individuals are genetically predisposed to antisocial behaviors, environmental stimuli also play a role in whether those behaviors manifest. Those with certain genes related to neurotransmitters like serotonin are more susceptible. Lithium is known to impact these neurotransmitter systems and has shown success in treating conditions like bipolar disorder. The document proposes low-level lithium supplementation as a way to potentially help reduce antisocial behaviors in those genetically at risk who would not otherwise seek treatment due to lack of awareness of their condition.